Opioid Education for Post-Surgery in Breast Cancer
(SAVE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a short educational video about safe opioid use helps breast reconstruction patients manage their post-surgery pain medication more effectively. The video covers the opioid crisis, safe opioid use, and proper disposal. Participants will be divided into two groups: one will watch the video, while the other will receive standard care without it. Women undergoing breast reconstruction surgery using tissue from their abdomen after a mastectomy are ideal candidates for this study. The goal is to improve opioid prescribing and usage after surgery, potentially benefiting other surgical areas in the future. As an unphased trial, this study allows patients to contribute to important research that could enhance post-surgical care practices.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It focuses on educating about opioid use after surgery.
What prior data suggests that this educational intervention is safe?
Research has shown that watching an educational video about opioids is safe. Participants in this study will watch a video, which is neither a drug nor a medical treatment, and thus has no physical side effects. The video aims to educate about the use and disposal of opioids. This method is expected to be manageable, as it solely provides information without altering medication or introducing new treatments.12345
Why are researchers excited about this trial?
Researchers are excited about the opioid educational video because it offers a fresh approach to managing opioid use in post-surgery breast cancer patients. Unlike traditional care, which primarily relies on prescribing medications and providing written guidelines, this video aims to educate patients through a short, easily understandable video format before surgery. By enhancing patient understanding of proper opioid use, the video could help reduce the risk of misuse and improve pain management, potentially leading to better overall outcomes and a more informed patient experience.
What evidence suggests that this opioid educational video is effective for post-surgery in breast cancer?
Research has shown that educational videos about safe opioid use can help patients take fewer opioids after surgery. In this trial, participants in the "Opioid Video" arm will watch a 3-minute educational video on proper opioid use before surgery. One study found that teaching patients how to use opioids correctly led to less opioid use in breast reconstruction patients. Another study demonstrated that digital education could help manage pain and reduce the need for opioids after breast cancer surgery. By informing patients about the opioid crisis and how to use and dispose of opioids safely, these videos aim to prevent long-term opioid use. This method could lead to new guidelines for prescribing opioids after surgery.12678
Who Is on the Research Team?
Jay Agarwal, MD
Principal Investigator
Huntsman Cancer Institute/ University of Utah
Are You a Good Fit for This Trial?
The SAVE Trial is for patients undergoing breast reconstruction after breast cancer who will be prescribed opioids post-surgery. Participants must be willing to watch an educational video about opioid use and disposal. Specific inclusion and exclusion criteria are not detailed here.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Preoperative Education
Participants in the opioid video cohort watch a 3-minute education video on proper opioid use preoperatively
Postoperative Monitoring
Participants are monitored for opioid consumption and complications post-discharge
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Opioid Educational Video
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Utah
Lead Sponsor